Bookmark and Share

Rana  Malek

Rana Malek M.D.

Academic Title: Assistant Professor
Primary Appointment: Medicine
Location: 827 Linden Avenue, Second Floor
Phone: (443) 682-6800
Fax: (410) 856-3840

Personal History:

Dr. Malek graduated from the University of Maryland School of Medicine in 2003. She completed her residency in internal medicine at Emory University School of Medicine in 2006. She completed her fellowship in endocrinology at the National Institutes of Health in 2009. She is board certified in both internal medicine and endocrinology, diabetes, and metabolism. She is the program director for the Endocrinology and Diabetes Fellowship at the University of Maryland Medical Center.

Clinical Specialty:

Dr. Malek sees patients at the University of Maryland Center for Diabetes and Endocrinology at the Midtown campus.

Dr. Malek has extensive experience managing patients with both type 1 and 2 diabetes mellitus. She uses continuous glucose monitors and insulin pumps to manage complicated diabetes cases. She works as part of a multi-disciplinary team to improve the care of all her patients with diabetes. She has both clinical and research experience managing patients with extreme insulin resistance.

In her endocrine practice, Dr. Malek has a clinical interest in metabolic health, with a focus on management of lipid disorders, pre-diabetes, gestational diabetes, polycystic ovarian syndrome, and congenital adrenal hyperplasia.  She is currently involved in research to increase access to care for women with a history of gestational diabetes.

New patients can call 443-682-6800 to schedule appointments.


  1. Malek R, McCarthy-Keith D, Levens E, Merino MJ, DeCherney AH, Weinstein LH. A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries. Endocr Pract 2008; 14(7) 898-901.
  2. Skarulis MC, Celi FC, Mueller E, Zemskova M, Malek R, Hugendubler L, Cochran C, Solomon J, Chen C, Gorden P. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab 2010; 95(1) 256-262.
  3. Malek R, Chong AY, Lupsa BC, Lungu AO, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P. Treatment of type B insulin resistance: A novel approach to reduce insulin receptor auto-antibodies. J Clin Endocrinol Metab 2010; 95(8) 3641-3647.
  4. Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, Zerfas P, Zhigang D, Wright EC, Stuelten C, Sun P, Lonning S, Skarulis M, Sumner AE, Finkel T, Rane SG. Protection from obesity and diabetes by blockade of TGF-ß/Smad3 signaling. Cell Metab 2011; 14(1) 67-79.
  5. Feigenbaum K, Brooks PG, Chamberlain CE, Cochran E, Adams-McLean A, Malek R, Harlan DM. The clinical center's blood glucose management service: A story in quality integrated care. Diabetes Educ 2012; 38(2) 194-206.
  6. Pavlatou MG, Vickers KC, Varma S, Malek R, Sampson M, Remaley AT, Gold PW, Skarulis MC, Kino T. Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects. Obesity 2013; 21(5) 960-7.
  7. Price JD, Linder G, Li WP, Zimmermann B, Rother KI, Malek R, Alattar M, Tarbell KV. Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study. Clin Exp Immunol 2013; 174(1) 120-8.
  8. Manikas ED, Isaac I, Semple RK, Malek R, Fuhrer D, Moeller LC. Successful treatment of type B insulin resistance with rituximab. J Clin Endocrinol Metab 2015; 12:jc20143552. [Epub ahead of print].
  9. Kant R, Loper HB, Verma V, Malek, R, Drachenberg C, Munir K. Glycogen hepatopathy with persistent hepatomegaly in a patient with uncontrolled type 1 diabetes. J Endocrinol Metab. 2015;5(1-2):189-191